48.89USDMkt Cap: 3.39B $P/E: —1d ago
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which c…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap3.39B $
Enterprise Value3.13B $
Revenue (TTM)18.67M $
Gross Profit14.41M $
Net Income (TTM)-198.97M $
Revenue/Share0.2990 USD
Last Price48.89 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees221
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.28
PEG—
EV/EBITDA-17.13
EV/Revenue167.80
P/S181.63
P/B10.46
EPS (TTM)-4.06
EPS (Forward)-3.00
52W Range
47.0971% of range49.64
52W High49.64 USD
52W Low47.09 USD
Profitability
Gross Margin89.53%
Oper. Margin-872.23%
EBITDA Margin0.00%
Profit Margin-1236.00%
ROE-100.04%
ROA-24.12%
Growth
Revenue Growth11.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-177.96M $
CapEx (TTM)439.00K $
FCF Margin-415.49%
FCF Yield-2.29%
Net Debt-258.17M $
Net Debt/EBITDA1.41
Balance Sheet
Debt/Equity0.32
Current Ratio10.01
Quick Ratio9.79
Book Value/Sh4.674 USD
Cash/Share11.68 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)70.40 USD
Upside (mean)+44.0%
Target Range47.25 USD – 97.58 USD
$47.25+44.0% to mean$97.58
# Analysts11
Ownership
Shares Out.69.37M
Float57.52M
Insiders1.26%
Institutions96.19%
Short Interest
Short Ratio6.8d
Short % Float15.61%
Short % Out.15.40%
Shares Short10.68M
Short (prev mo.)11.49M
Technical
SMA 5041.84 (+16.9%)
SMA 20027.42 (+78.3%)
Beta0.94
S&P 52W Chg21.00%
Avg Vol (30d)1.20M
Avg Vol (10d)1.06M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—